Hind limb unloading of mice modulates gene expression at the protein and mRNA level in mesenchymal bone cells by Davide Visigalli et al.
Visigalli et al. BMC Musculoskeletal Disorders 2010, 11:147
http://www.biomedcentral.com/1471-2474/11/147
Open AccessR E S E A R C H  A R T I C L EResearch articleHind limb unloading of mice modulates gene 
expression at the protein and mRNA level in 
mesenchymal bone cells
Davide Visigalli1, Antonella Strangio2, Daniela Palmieri1 and Paola Manduca*1
Abstract
Background: We investigated the extent, modalities and reversibility of changes at cellular level in the expression of 
genes and proteins occurring upon Hind limb unloading (HU) in the tibiae of young C57BL/6J male mice. We focused 
on the effects of HU in chondrogenic, osteogenic, and marrow mesenchymal cells.
Methods: We analyzed for expression of genes and proteins at two time points after HU (7 and 14 days), and at 14 days 
after recovery from HU. Levels of mRNAs were tested by in situ hybridization. Protein levels were tested by 
immunohistochemistry. We studied genes involved in osteogenesis (alkaline phosphatase (AP), osteocalcin (OC), 
bonesialoprotein (BSP), membrane type1 matrix metalloproteinase (MT1-MMP)), in extracellular matrix (ECM) 
formation (procollagenases (BMP1), procollagenase enhancer proteins (PCOLCE)) and remodeling (metalloproteinase-
9 (MMP9), RECK), and in bone homeostasis (Stro-1, CXCL12, CXCR4, CD146).
Results: We report the following patterns and timing of changes in gene expression induced by HU: 1) transient or 
stable down modulations of differentiation-associated genes (AP, OC), genes of matrix formation, maturation and 
remodelling, (BMP1, PCOLCEs MMP9) in osteogenic, chondrogenic and bone marrow cells; 2) up modulation of MT1-
MMP in these same cells, and uncoupling of its expression from that of AP; 3) transient down modulation of the 
osteoblast specific expression of BSP; 4) for genes involved in bone homeostasis, up modulation in bone marrow cells 
at distal epiphysis for CXCR4, down modulation of CXCL12, and transient increases in osteoblasts and marrow cells for 
Stro1. 14 days after limb reloading expression returned to control levels for most genes and proteins in most cell types, 
except AP in all cells, and CXCL12, only in bone marrow.
Conclusions: HU induces the coordinated modulation of gene expression in different mesenchymal cell types and 
microenvironments of tibia. HU also induces specific patterns of expression for homeostasis related genes and 
modulation of mRNAs and proteins for ECM deposition, maturation and remodeling which may be key factors for bone 
maintenance.
Background
Bone loss may be induced by immobilization of humans
for long times in bed, and by hind limb unloading of
rodents. HU allows ex vivo investigations into the pro-
cesses and effects of weightlessness in long bones [1,2].
Effects of HU have been detected earliest on the viability
of osteoblasts [3], followed by apoptosis of the osteocytes,
activation of osteoclastogenesis and loss in bone mass,
attributed to altered mechano-transduction by osteo-
blasts [4]. HU-induced changes in the expression of dif-
ferentiation-associated genes have been reported in
studies on whole bone tissue [5]. In ex-vivo experiments
in rats, HU determined the decrease in number of colony
forming cells from the bone marrow osteogenic compart-
ment, and in AP expressing colonies [6].
The expression of differentiation-associated genes in
osteoblasts and preosteoblasts is altered in simulated
microgravity conditions, reproducing in vitro the condi-
tion of reduced mechanical stress occurring in space
flight and in HU [7-9]. In microgravity, adipocyte differ-
entiation is promoted from mesenchymal precursor cells
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Page 2 of 13[10] and collagen I synthesis is impaired in osteogenic
and fibroblastic cells [7-9,11]. Osteopontin and parathy-
roid hormone receptor have been associated with the
modulation of bone loss in HU conditions [12,13].
Studies are needed to illustrate the changes in gene
expression at the level of individual mesenchymal cell
types in the bone of HU animals, and to find more infor-
mation on the expression of proteins. In addition, no data
are available on the effects of HU on genes governing
matrix deposition and remodeling, or on genes involved
in controlling the homeostasis of the different cell types
in bone. Little is known about the timing of the modula-
tion in different cell types for each of the responsive genes
by HU. Reversibility of these changes once weight is re-
applied to the limbs is poorly understood.
In this paper we report investigations to start filling
these gaps and suggest that valuable information can be
obtained by studying the regulation by HU of proteinases
and chemokine genes and proteins at cellular levels, in
association with classic osteogenic markers.
We determined by in situ hybridization and/or immu-
nohistochemistry the expression of individual genes and
proteins in the tibiae of 11 week old male mice C57BL/6J,
after HU for 7 and 14 days. We focus our report on gene
expression in chondrocytes at the growth plate, osteo-
cytes, endosteum and trabecular lining osteoblasts and in
bone marrow cells.
Changes in the growth plate, and then in bone mor-
phology, occurred after 3, 7 and 14 days and were docu-
mented. Bone loss was quantified by microcomputed
tomography analysis (μCT) at 14 days. We also studied
the expression of genes in tibiae of animals kept in HU for
14 days and then set on the ground for the next 14 days
(re-loading). We compared same age control, and HU
mice for the expression of key genes associated to the dif-
ferentiation of osteoblasts (AP, OC, BSP), of genes
involved in the deposition of ECM (BMP-1 and
PCOLCE1 and 2) and in its remodeling (MT1-MMP,
MMP-9, RECK), and of genes implied in bone homeosta-
sis (Stro1, CD146, CXCR4 and CXCL12).
A decrease in AP and OC expression was previously
described by examining mRNA from whole bones of HU
rodents [14]. BMP1, mammalian tolloid (mTLD) and the
genes for PCOLCE1 and 2, are expressed in modulated
fashion during in vitro osteogenesis in rat osteoblasts
(Manduca et al unpublished); the level of expression of
their proteins controls the rate and amount of deposition
of collagen fibers and the activation of pro-lysyl oxidase,
also involved in the deposition of collagen fibrils [15,16].
PCOLCEs and BSP, known to be highly expressed by
osteoblasts and osteoclasts [17], are proteins with a role
in the mineralization of the ECM and PCOLCE1 is an
important determinant of bone mechanical properties
and of the geometry and morphology of collagen fibrils in
mammals [18,19]. PCOLCEs gene expression decreases
in osteoblasts cultured in microgravity [7].
Enzymes remodeling the ECM emerged as important
for the osteogenic progression [20-22]. The major MMPs
family members expressed by differentiating osteoblasts,
MT1-MMP, MMP-2 and -9 are developmentally regu-
lated during osteogenesis in vitro [21]. In rat osteoblasts
differentiating in vitro, MT1-MMP expression affects the
expression of pro-MMP-2 and of AP, and the activation of
pro-MMP-2 pleiotropically [22]. MMP-9 modulation is
not apparently associated with that of the other MMPs.
RECK is an endogenous membrane inhibitor of MMPs
[23], also modulated in its expression during osteogenesis
in vitro [24].
CXCR4 [25] is the receptor for Stromal cell-derived fac-
tor-1 (SDF-1 or CXCL12), which is constitutively
secreted by osteoblasts and bone marrow stromal cells.
Dynamic levels of CXCL12 and CXCR4 expression play a
key role in the homing of hematopoietic cells to the bone
marrow, in the mobilization of circulating osteoblast pre-
cursors and in the recruitment of bone-resorbing osteo-
clasts, of osteoblasts, neutrophils, and other myeloid cells
[26]. Activation of the CXCR4/CXCL12 pathway induces
proliferation of hematopoietic and mesenchymal progen-
itors [27]. CXCL12 also stimulates mononucleate cell
fusion and TRAP activity and is a key factor in the normal
homeostatic regulation of bone development and remod-
eling [28]. CD146 is an endothelial, smooth muscle cell
and pericyte marker [29] and Stro1 a stage- and/or lin-
eage-specific stromal antigen [30].
Our results show that HU modulates the expression of
the osteogenic differentiation markers AP, MT1-MMP,
BSP and OC consistently in all the cells expressing these
genes, even if of different differentiation lineages. Uncou-
pling of the associated expression for AP and MT1-MMP
occurs in cells of the osteogenic lineage.
HU modulates proteolysis related genes suggesting that
pericellular proteolysis may be specifically increased. HU
affects the expression of genes for matrix deposition and
maturation, BMP1 and PCOLCEs, in the growth plate
and in the bone cells, suggesting a lesser formation of
cross linked collagen fibers and impaired bone matrix
maturation.
Changes in the pattern of expression observed in cells
of the distal bone marrow for genes involved in bone
homeostasis, Stro1, CXCR4 and CXCL12, suggest that
complex changes in bone homeostasis may occur in HU
mice, apparently not involving CD146 expression.
Return to pre-treatment levels of gene expression for
most genes studied occurs after the mice in HU for 14
days were set on the ground again for 14 days, with the
exception of AP in all cells and CXCR4/CXCL12 in bone
marrow at the distal epiphysis.
Visigalli et al. BMC Musculoskeletal Disorders 2010, 11:147
http://www.biomedcentral.com/1471-2474/11/147
Page 3 of 13Methods
Hindlimb unloading
11 week old C57BL/6J male mice (Charles River, Italy)
were suspended for the tail in a special cage [31,32], a
condition referred as HU, for 3, 7 or 14 days. Food and
water were ad libitum. Control of the amount of food
uptake showed no differences at any time among the
groups of animals in different conditions. In each experi-
ment 3 to 6 mice were HU for each time point and the
same number were kept on the ground as control. Re-
loading of the hind limb occurred by returning mice to
standard conditions for 14 days after HU. Animal treat-
ment was in accordance with the Italian Guidelines for
the use of laboratory animals, which conforms with the
European Community Directive published in 1986 (86/
609/EEC).
Microcomputed Tomographic (μCT) Analysis
Whole femora (one per mouse) were examined by a μCT
system (Desktop μCT 40, Scanco Medical AG, Bassers-
dorf, Switzerland) at the Bone Laboratory of The Hebrew
University of Jerusalem, courtesy of Prof. I. Bab and Dr.
A. Bajayo, as reported previously [33]. Scans were per-
formed at a 20 μm resolution in all three spatial dimen-
sions and all morphometric parameters were determined
using a direct 3-D approach. Three preselected regions:
1) whole bone; 2) secondary spongiosa in the distal meta-
physis extending proximally 3 mm from the proximal tip
of the primary spongiosa; 3) a diaphyseal segment
extending 1 mm distally from the midpoint between the
femoral ends. For the whole bone we determined the
Apparent Volume Density (AVD) [34]. Parameters deter-
mined in the metaphyseal trabecular bone included bone
volume density (BV/TV), trabecular thickness (Tb.Th),
trabecular number (Tb.N) and trabecular connectivity
(Conn.D). Cortical thickness (Cort.Th), diaphyseal diam-
eter (Dia.Dia) and the medullary cavity diameter
(Med.Dia) were determined in the mid-diaphyseal region.
Preparation for immunohistochemistry and in situ 
hybridization
Tibiae were dissected free of soft tissues and fixed in PAF
4% in PBS 1× a 4°C for 48 hours, decalcified with Osteo-
dec (Bioptica, Italy) for 16 hours, dehydrated by succes-
sive alcohol passages and xylol washing and embedded in
paraffin at 58°C. Sections at the microtome were 4 μm
thick and the sections in the central portion of the bone
were stained with H.E. or used for immunohystochemis-
try and in situ hybridization.
Immunohistochemistry
De-paraffinized sections were processed by citrate
unmasking of the antigens at 95°C, peroxidase quench-
ing, rinsed in PBS and incubated with the primary anti-
body for 60' at room temperature, followed by rinses and
incubation for 60' with the secondary antibody (HRP
polymer conjugate broad spectrum DAB kit from Zymed
Laboratories inc., cat. 87-9663). Counterstaining was
with Hematoxylin. Controls were run omitting the pri-
mary antibody. Primary antibodies (all utilized at 1/50
dilution) were: CXCL12 polyclonal in rabbit (sc-28876,
Santa Cruz), RECK polyclonal in rabbit (sc-28918, Santa
Cruz), BSP polyclonal in rabbit (LF87, kindly donated by
Prof. L.W. Fisher, Bethesda, USA), BMP-1 polyclonal in
rabbit (sc-33200, Santa Cruz, USA, recognizing all splic-
ing variants and Tll1, Tll2 protein), OC polyclonal in rab-
bit (sc-30045, Santa Cruz, USA), CD146 polyclonal in
rabbit (sc-28667, Santa Cruz, USA) and Stro-1 mouse
ascites (kindly donated by Prof. Ranieri Cancedda, CBA,
Genoa, Italy). We show exemplary micrographs from at
least two experiments of HU and 2 or 3 mice for each
condition from each experiment, which gave consistent
results.
In situ hybridization
Probes utilized were: AP (NM_007431) 600 bp cDNA
cloned in PBSSK plasmid, kindly donated by Prof. Tuan;
OC (NM_007541) 350 bp cDNA cloned in PBSSK plas-
mid, kindly donated by Prof J.E. Aubin (recognizing all
three genes including in the osteocalcin cluster [35]);
MT1-MMP (NM_008608) 1021 bp cDNA cloned in
PBSSK, kindly donated by Prof. Lewalle; BMP1
(NM_009755) 827 bp cDNA cloned in PSP65 plasmid,
kindly donated by Prof. Wozney (recognizing BMP1 and
all variants differently spliced); MMP-9 (NM_013599)
676 bp cDNA cloned in PUC19 plasmid, kindly donated
by Prof. W.G. Stetler-Stevenson: VEGF-A, 700 bp cDNA
cloned by RT-PCR with the PCR TA cloning kit (Invitro-
gen, USA) from human total RNA in PCR 2.1 vector
(primers for human VEGF-A: Lp CCTTGCTGCTCTAC-
CTCCAC Rp TCTGTCGATGGTGATGGTGT, recogniz-
ing all VEGF-A mRNA splicing variants); CXCR4
(NM_009911) 692 bp cDNA cloned by RT-PCR with
PCR-Script Amp cloning kit (Stratagene, USA) from
human total RNA in pPCR-script amp SK(+) vector
(primers for human CXCR4: Lp ATGCAAGGCAGTC-
CATGTCAT Rp TCTGTCGATGGTGATGGTGT [36],
recognizing the two mRNA splicing variants) and
PCOLCE (NM_008788) 501 bp cDNA cloned by RT-PCR
from rat total RNA in PBSSK vector (primers for rat
PCOLCE: Lp ATGCTCTGGAGGTCTTTGCT Rp
TGAGATCTGATACAAACTGG, recognizing the genes
for PCOLCE1 and PCOLCE2). Linearized plasmids were
used with dig-labeling nucleic acids kit (Boeringher-
Mannheim, Germany) to obtain sense or antisense digox-
igenin-labeled riboprobes from the appropriate pro-
moter. Hybridization reactions were performed on serial
sections of 4 μm thick, de-paraffinized, dehydrated and
post-fixed with 4% PAF pH 9.5 in PBS 1× [37]. After
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37°C, hybridization was in 3× SSC, 1 mg/ml tRNA, 10
mM DTT, Denhardt's solution 1×, 50% formamide, 1 mg/
ml denatured salmon sperm, 10% dextran sulfate and 1
ng/μl of the denaturated probe, maintained overnight at
high stringency. Temperatures of annealing and strin-
gency of washes were optimized for each probe [38]. The
slides were washed in 2× SSC, digested with RNAse A
100 μg/ml at 37°C, incubated overnight at 4°C with anti-
digoxigenin Fab fragments conjugated to alkaline phos-
phatase (Boeringher-Mannheim, Germany) in buffer
with 1.5 M NaCl, 0.1 M TRIS-HCl, 2 mM MgCl2, 0.3%
Triton X-100, 10% fetal calf serum, pH 7.5. Color devel-
opment was in buffer 0.1 M NaCl, 0.1 M TRIZMA base, 5
mM MgCl2, 10% polyvinyl alcohol 89-98 kDa (Sigma,
USA), 1 mM levamisole (Sigma, USA), 0.16 mg/ml BCIP,
0.33 mg/ml NBT (Roche, Germany), pH 9.5, for 3-6 hours
at 30°C [39]. Slides were counterstained with nuclear fast
red 0.005% and mounted in glycerol gelatin (Sigma,
USA). We show exemplary micrographs from at least two
experiments of HU, and 3 mice for each condition and
from each experiment, which gave consistent results.
Image acquisition
The images were captured with a Leica DMBR micro-
scope mounted with a Leica camera DFC320 and
acquired with Leica Firecam version 1.9.1.
Statistics
For mice weight a one-way ANOVA test was performed
to define significance.
Results
We examined 3 mice for each time point of HU in each of
2 or 3 separate experiments compared with equal num-
bers of control mice. No significant differences in body
weight were found in HU mice compared with age
matched control mice during all the experimental peri-
ods, nor with mice kept in HU for 14 days plus 14 days
after reloading of hind limbs (Figure 1A). This shows lack
of significant growth during the experimental time and
suggests lack of stress due to the HU condition.
Figure 1B shows the morphology of growth plate, dia-
physeal endosteum and bone marrow in the distal epiph-
ysis of controls and in mice kept for 3, 7 or 14 days in HU.
3 days after HU, the cartilage at growth plate already
shows a disrupted columnar arrangement, with loss of
the connection to the morphologically unchanged trabe-
cular organization underneath. Osteogenic cells, here
shown lining the endosteum at diaphysis, but equally on
trabeculae (not shown), became disorganized and fewer
after 7 days of HU. At this time no obvious thinning of the
diaphyseal bone was detected. 14 days after HU, the tra-
beculae appear severely disarranged and have reduced
thickness. This observation is more evident in the micro-
graph at low enlargement including the whole proximal
epiphysis. Bone marrow in the distal epiphysis shows
decrease in cellularity after 14 days in HU, which might
be due to increase in size/number of adipocytes.
Quantitative μCT analysis shows significant HU-
induced decreases in total bone volume (AVD, 26%)
which is the percent mineralized tissue volume over the
total bone volume defined by the external bone envelope.
Also decreased are trabecular bone volume (51%), trabec-
ular thickness (20%), and connectivity density (66%) at 14
days in HU. The diaphyseal diameter shows a 57 μm
decrease (28.5 μm in diaphyseal radius). In the absence of
a parallel significant reduction in the medullar cavity
diameter, this decrease results in 16 μm thinning of the
cortex (Figure 1C). Substantial cortical and trabecular
bone loss, with disorganization of trabecular architec-
ture, is evident after 14-days HU (Figure 1D).
We examined gene expression by in situ hybridization
and protein expression by immunohistochemistry. We
could not detect changes in gene expression in mice after
3 days of HU. We here report, summarized in Table 1, the
changes observed in gene expression in mice after 7 and
14 days of HU in comparison with matched age controls.
Expression levels in control mice remained constant at
each time within the 28 day experimental period, and so
for each of the figures below, we only show the data from
controls at 14 days. In each of the figures images show in
sequence from left to right in the panel columnar pre-
hypertrophic chondrocytes, osteoblasts on endosteum
and on trabeculae, in bone marrow cells in the central
diaphysis and in the distal epiphysis.
Among the genes characterizing the osteogenic pro-
gression, the mRNA for AP (Figure 2, top-left) is
expressed in control mice in all these cells, with lesser
intensity in those in the distal epiphysis. Its amount
decreases severely after 7 days of HU (HU7) and remains
low at 14 days of HU (HU14) in pre-hypertrophic chon-
drocytes, osteoblasts on endosteum, and a smaller
decrease is detected in bone marrow cells at the distal
epiphysis. The level of AP mRNA does not return to con-
trol level in HU14 mice recovering on the ground for 14
days (HU14+R14).
The three genes included in the OC cluster detected by
our RNA probe are expressed in the same cell types
expressing AP (Figure 2, top-right). The level of OC
mRNAs is transiently decreased in all cell types after 7
days of HU, and returns to control level during the second
week of HU. The transient decrease of mRNA in HU mice
is reflected on the protein level (immunohistochemistry
in Figure 2, bottom-right) which is lower than controls
after 7 days (not shown), remains low up to 14 days of
HU, and partly increases after recovery.
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restricted to osteogenic and bone marrow cells. Com-
pared to controls, the protein level transiently decreases
after 7 days of HU and returns to control levels after 14
days of HU.
MT1-MMP expression occurs in the same cell types as
those expressing AP, and its mRNA increases in HU7 and
HU14 mice (Figure 3, top-left). The level of gene expres-
sion decreases after recovery. All the cell types that
express MT1-MMP show a similar pattern and timing of
change in gene expression during HU and after recovery.
MMP-9 mRNA (Figure 3, top-right) is expressed in
chondrogenic, osteogenic, bone marrow mesenchymal
cells and macrophages. The expression of the transcript is
progressively decreased during the two weeks of HU,
compared to control, and returns to a level similar to con-
trol after recovery.
The expression of the protein for the endogenous
inhibitor of MMPs, RECK (Figure 3, bottom) is observed
in osteoblasts and in mesenchymal cells under the growth
plate. The amount of RECK transiently decreases after 7
days of HU in all cell types, returns to control levels after
14 days of HU, and no further changes occur after recov-
ery for 14 days (not shown).
The expression of BMP1 and PCOLCE1, 2 occurs in the
same cell types expressing AP. 14 days after HU is
detected down modulation in the levels of expression for
mRNAs (Figure 4, top-left) and proteins (Figure 4, bot-
Figure 1 Growth unaffected in HU mice, and changes in bone histomorphometry. A- Mice weight (mean +/- SEM). The values are obtained from 
the measure of the weight of 6 mice per point for each condition, below. Means +/- SEM. One-way ANOVA shows no significant difference for p < 
0.05. B- Photomicrographs of Hematoxylin-Eosin. Stained sections from tibiae of mice at different days in HU were taken at the growth plate, cortical 
bone at mid-diaphysis, bone marrow in the distal region of the tibia. Enlargement is 200×. On the bottom the whole of the proximal epiphysis, 40×. 
C- Bone morphometric parameters by μCT, in control and HU14 mice. Apparent volume density (AVD), trabecular bone volume density (BV/TV trabe-
cular), trabecular thickness (Tb.Th), trabecular number (Tb.N), connectivity density (Conn.D), diaphyseal diameter (Dia.Dia), cortical thickness (Cort.Th), 
medullary cavity diameter (Med.Dia). Data are mean ± SEM obtained in 6 mice per condition. *, p < 0.05. Black columns control, white columns HU14. 
D- 3D μCT femoral images from control and HU for 14 days.
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mRNA Vs. control HU7 HU14 HU14+R14 expressed in
AP | | | growth plate chondrocytes, osteogenic, bone 
marrow cells
OC | = = growth plate chondrocytes, osteogenic, bone 
marrow cells
MT1-MMP 9 9 = growth plate chondrocytes, osteogenic, bone 
marrow cells
MMP9 = | = growth plate chondrocytes, osteogenic, bone 
marrow cells, macrophages
BMP1 = (ns) | = growth plate chondrocytes, osteogenic, bone 
marrow cells
PCOLCEs = | = (|distal bone marrow) growth plate chondrocytes, osteogenic, bone 
marrow cells
CXCR4 = (ns) 9 = osteogenic, bone marrow cells
Protein vs. 
control
HU7 HU14 HU14+R14 expressed in
OC ND | = growth plate chondrocytes, osteogenic, bone 
marrow cells
BSP | = (|osteoblasts) ND osteogenic, bone marrow cells
RECK | = ND osteogenic cells
BMP1 = (ns) | = growth plate chondrocytes, osteogenic, bone 
marrow cells
Stro1 9 = ND osteogenic, bone marrow cells
CXCL12 ND | = (only osteoblasts) bone marrow cells
Arrows pointing upwards indicate increase, pointing down indicate decrease of expression related to the corresponding control; = stays for 
equal to control. ND, not done; ns, not shown in the corresponding figure.
tom-left), and the mRNA level is restored after recovery
for 14 days.
The modulation of expression of mRNAs for the
PCOLCE 1,2 (Figure 4, top-right), is similar to that of
BMP1, with a decrease detected after 14 days of HU, and
returning to control level after recovery for 14 days.
Stromal protein Stro1 (Figure 5, top-left) is expressed in
osteogenic and bone marrow cells and is transiently up
modulated after 7 days of HU.
The CXCL12 protein is detected in controls with high-
est expression in the bone marrow cells (Figure 5, top-
right) and is down modulated in HU14 mice; after recov-
ery for 14 days the protein is detected again in bone cells
and also in the osteocytes within the trabeculae, but its
expression is not restored in the cells of the distal bone
marrow.
The expression of the mRNA for the CXCL12 receptor,
CXCR4, is detected in bone and bone marrow cells (Fig-
Visigalli et al. BMC Musculoskeletal Disorders 2010, 11:147
http://www.biomedcentral.com/1471-2474/11/147
Page 7 of 13ure 5, third panel from the top), is highly up modulated in
the bone marrow at distal epiphysis after 14 days of HU
and only slightly decreases after recovery.
Immunostaining for the stromal protein CD146 and in
situ hybridization for VEGF (with a probe detecting the 3
forms of VEGF-A) were also done, and these genes did
not show significant differences between control and HU
mice (not shown).
Discussion
We report the evidences of modulation of the expression
of genes and proteins in mesenchymal cells of mice tibia
during HU. We also report the restoration of control gene
and protein expression after re-loading of the limbs for 14
days.
Although in HU rodents the osteoblasts and mesenchy-
mal osteogenic precursors were identified as the first cel-
lular component responding to the lack of weight bearing
with increased apoptosis [3], the effects of HU on gene
expression at the cellular level in mesenchymal cells was
not previously studied [5-9] and no information was
available about how HU affects the expression of genes
involved in the deposition, organization and remodeling
of ECM.
We investigated either gene and/or protein expression,
according to the availability of probes, as summarized in
Table 1.
We show that HU can modulate the expression not only
of genes involved in osteogenesis, but also of genes
involved in ECM proteolysis and deposition, and of genes
involved in the homeostasis of bone.
The modulation by HU of many genes and proteins
occurs at the same time and with the same sign (increase
or decrease of expression) in the cells residing in different
tissue microenvironments of the long bone, with the
exceptions described below for bone marrow in the distal
epiphysis.
In control mice co-expression of AP, MT1-MMP, OC,
MMP-9, PCOLCEs and BMP1 occurs in chondrogenic,
osteogenic and bone marrow mesenchymal cells, while
BSP, Stro1, VEGF-A and CD146 (these last two not
shown) and CXCR4 expression are restricted to osteo-
genic and bone marrow cells. RECK expression is local-
ized to osteoblasts at the endosteum and under the
growth plate, and CXCL12 expression to bone marrow
cells.
No changes were detected after 3 days of HU but
changes in gene and protein expression were evident by 7
days as decreases in the levels of AP, OC, BSP, RECK, and
increases in the levels of MT1-MMP and Stro1. At this
time disorganization of the trabecular arrangement at the
growth plate and changes in the morphology of the osteo-
blasts lining the endosteum were already evident, but no
obvious thinning of the diaphyseal bone was detected.
After 14 days of HU, bone erosion was measured and
decreases in the level of expression of MMP 9, BMP1 and
PCOLCEs, CXCR4, CXCL12 were detected. The changes
in gene expression observed after 7 days of HU persisted
and/or were enhanced for some genes, (as the decrease in
AP and the increase in MT1-MMP), while for other genes
and proteins the level of expression reverted to that of the
control (as for OC, BSP, RECK, Stro1).
Recovery on the ground for 14 days, after 14 days of
HU, determined return to control level and reversal of the
changes induced by HU, for expression of all the genes
and proteins in chondrocytes at the growth plate and for
osteoblasts and bone marrow cells in proximal and mid
tibiae, with the exception of AP. This observation is in
agreement with the slow recovery of AP expression after
HU in rodents, in man and other mammals after space
flight.
Whereas AP expression decreased and was not revers-
ible by re-loading, MT1-MMP expression increased dur-
ing HU and returned to control by 14 days after limb re-
loading. This evidence suggests that the positive pleiotro-
phism that couples MT1-MMP and AP expression during
osteogenesis [22] was disrupted during HU.
In general, and with the exceptions below, synchrony
and similarity in direction of the changes induced by HU
and occurring upon recovery were observed in all the
mesenchymal cells of different lineages and in the context
of different local microenvironments. This suggests that a
common mechanism for response to mechanical forces is
activated in all cell types, and mediates the sensing of the
changes induced by unloading, causing responses at cel-
lular level. This mechanism would be independent from
the different composition and characteristic of the local
ECM, such as in cartilage, bone or bone marrow.
We suggest that MT1-MMP, expressed in all the cell
types residing in these different ECMs, may play a key
role in sensing the mechanical changes induced by HU.
MT1-MMP expression is know to be modulated by
mechanical forces [39], and biochemical microenviron-
ment [40], and has the potential to "sense" the interaction
with ECM [18], which in turn can affect the expression of
other genes.
The increase in pericellular proteolysis, in pro-MMP-2
activation and in MT1-MMP self-regulation, ensuing
from MT1-MMP up modulation by HU, can play a key
role in the remodeling of ECM during HU, in association
with the decrease of the activity of MMP-9. This may
determine the establishment, and possibly the mainte-
nance, of a novel pericellular microenvironment. At the
same time, transient down modulation of BSP and RECK
in the osteogenic cells can specifically affect the organiza-
tion of mature bone ECM. These events might be associ-
ated to the early apoptotic response of osteogenic cells to
HU. The early transient up modulation of Stro1 might
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compartment of bone marrow.
The decrease in procollagenase and PCOLCEs activi-
ties, occurring only after 7 days of HU, may then diminish
collagen fibrillogenesis and deposition of the novel ECMs
of the several kinds present in the long bone, contributing
to the loss of bone density.
The effects of HU on CXCR4 and CXCL12 in the tibia
are specifically localized to the compartment of distal
bone marrow. In general, this compartment has a distinct
response by comparison to the diaphyseal bone marrow,
e.g. it is preferentially enriched in adipocytes in HU ani-
mals and in other models of induced osteoporosis [41,42].
A specific pattern of HU-induced modulation was
found for the CXCL12 protein, highly expressed in the
bone marrow cells, which is down modulated after 14
days of HU. CXCL12 level was restored after recovery in
osteoblasts and in the osteocytes within the trabeculae,
but not in the bone marrow. CXCR4, the CXCL12 recep-
tor, mRNA was up modulated after 14 days in HU, partic-
Figure 2 Changes in the pattern of expression of genes involved in the osteogenic progression (AP, OC and BSP) induced by HU, and their 
reversibility. Gene expression analyzed by in situ hybridization for AP, OC and by immunohistochemistry (for OC and BSP). Control mice at 14 days 
(C14) and mice in HU for 7 (HU7) or 14 days (HU14) and for 14 days in HU, followed by 14 days of re-loading (HU14+R14). From left to right in each 
row: growth plate, cortical bone at mid-diaphysis, trabecular bone in the proximal region, bone marrow in the distal region of the tibia. Arrows in the 
first lane point to different cell types in these compartments, respectively pre-hypertrophic columnar chondrocytes, osteogenic cells of the endoste-
um, osteogenic cells lining trabeculae and bone marrow cells. Probes are described in M&M. Enlargement is 200×.
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where it continued to be expressed at a relatively high
level also after recovery. The effects of HU on cells in the
bone marrow in the distal epiphysis might unbalance the
CXCR4/CXCL12 signaling at least regionally. In view of
the role that this signaling pathway plays in bridging
hematopoiesis, osteogenesis and osteoclastogenesis,
these effects might be relevant in the homeostasis of the
whole bone. Since CXCL12 expression did not return to
control level in the distal bone marrow after recovery, the
unbalance might persist and, the restoration of bone bal-
ance might lag.
In this report we have not mentioned gene expression
in multinucleated cells in the bone marrow and in osteo-
clasts; these are part of an ongoing study. We had prob-
lems focusing on osteocytes at the microscope, possibly
due to the relatively thick sections obtained from paraffin
embedded whole bones, which limited our report about
this cell type.
Conclusion
To summarize, the net effects at the cellular level of HU
treatment in mice were to depress the expression of genes
for osteogenic progression, to uncouple the expression of
Figure 3 Changes in the pattern of expression of genes involved in ECM proteolysis (MMP-9, MT1-MMP, RECK) induced by HU, and their 
reversibility. Gene expression analyzed by in situ hybridization for MT1-MMP and MMP9 and immunohistochemistry for RECK. Description as in leg-
end of Figure 2. N.B. one micrograph is missing from the panel due unsuitable photographic quality of the sections. The experimental data is available 
and was readable by direct microscopic inspection.
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Page 10 of 13AP and MT1-MMP, to decrease generalized ECM degra-
dation via down modulation of MMP-9, and to increase
the pericellular proteolysis due to increased expression of
MT1-MMP, in the presence of transiently decrease of the
MMPs-inhibitory protein RECK in the osteogenic cells.
Anabolic genes that govern collagen synthesis and depo-
sition in fibrils (procollagenases and their enhancer pro-
teins) were for the first time identified as targets of HU-
dependent inhibition in cartilage, bone marrow and bone
cells. This inhibition possibly aggravates the loss of
matrix mass, already known to occur during HU, due to
the reduction in collagen synthesis. The down-modula-
tion of these functions may also contribute, together with
the transient decrease of BSP protein in osteogenic cells,
to the specific impairment of the maturation of osteo-
genic matrix.
The simultaneous timing and direction of the response
to HU for genes involved in the osteogenic progression
and genes involved in proteolysis and deposition of the
ECM occurring in cells of different bone compartments
and lineages, suggests that it might exist a common pro-
cess of sensing the reduced gravity. We suggest that MT1-
MMP increase is a key element in this response, able to
mediate and influence further changes during HU. The
response to HU for specific genes involved in homeosta-
sis and localized to cells of the distal bone marrow points
the possibility that HU might affect the homeostatic bal-
ance of the whole bone; this point requires further studies
in vitro and in vivo.
No changes were detected in CD146 protein and for
VEGF-A.
Limb re-loading caused recovery of the previous pat-
tern of expression with the exceptions of AP in the whole
bone, and of CXCL12/CXCR4 in distal bone marrow.
This suggests that, at least in the experimental time ana-
lyzed, after re-loading of the limbs "all will not return as
well as before". Further investigation is particularly
important to define if and when the expression of these
Figure 4 Changes in the pattern of expression of genes involved in ECM deposition (BMP1, PCOLCE 1, 2) induced by HU, and their revers-
ibility. Gene expression analyzed by in situ hybridization for BMP1 and PCOLCE 1, 2. Description as in legend of Figure 2. For micrographs missing 
from the panel see legend Figure 3.
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sition of bone mass after re-loading.
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